Professor Raymond Schinazi Joins Board Of reViral As Non-Executive Director

LONDON, Apr 15, 2014 (PR Newswire Europe via COMTEX) -- LONDON, April 15, 2014 /PRNewswire/ --

reViral, an antiviral drug discovery and development company, focused on diseases caused by the respiratory syncytial virus (RSV), today announced the appointment of Professor Raymond Schinazi to its Board as a Non-Executive Director, effective from 9 April 2014.

Help employers find you! Check out all the jobs and post your resume.